Search for: "Hernandez v. Commissioner" Results 1 - 20 of 52
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Feb 2023, 4:49 am by Emma Snell
Sergio Hernandez, Sean O’Key, Amanda Watts, Byron Manley and Henrik Pettersson report for CNN. [read post]
26 Oct 2022, 4:42 am by Emma Snell
  Supreme Court Justice Samuel Alito yesterday called the leak of his draft opinion overturning Roe v. [read post]
20 Jul 2022, 4:52 am by Emma Snell
The Marquette Law School poll, which was conducted just days after the court overturned Roe v. [read post]
26 May 2022, 4:16 am by Emma Snell
Signup to receive the Early Edition in your inbox here. [read post]
12 May 2022, 4:24 am by Emma Snell
  RUSSIA, UKRAINE – MARIUPOL Thousands of civilians have been killed in the south-eastern city of Mariupol, and “the true scale” of alleged atrocities is yet to be revealed, United Nations High Commissioner for Human Rights Michelle Bachelet has said. [read post]
4 May 2022, 4:25 am by Emma Snell
’s Office of the High Commissioner for Human Rights reported the killings of almost 2,000 civilians in the conflict as of mid-April. [read post]
3 May 2022, 4:18 am by Emma Snell
High Commissioner for Human Rights Michelle Bachelet to make public comments condemning Kara-Murza’s detention. [read post]
26 Apr 2022, 4:22 am by Emma Snell
  E.U. energy commissioner Kadri Simson has announced that a sixth package of E.U. sanctions against Russia in response to its invasion of Ukraine is expected “very soon”. [read post]
12 Feb 2021, 3:00 am by Jim Sedor
With free legal aid from National Right to Work Legal Defense Foundation, Geary filed a federal complaint arguing the union infringed on her constitutionally protected rights under the foundation-won CWA v. [read post]
9 Mar 2020, 1:21 pm by Unknown
FDA and FTC Approaches to Help Ensure Truthful and Non‐misleading Advertising and Promotional Communications Lowell Schiller, Principal Associate Commissioner for Policy, FDA: have seen troubling communications suggesting biosimilars are less safe/less effective than reference products or that there may be clinically meaningful differences b/t them when biosimilars can’t be approved unless there are no clinically meaningful differences. [read post]